$INBS Intelligent Bio Solutions’ Innovative Drug
Post# of 24762
![Avatar](/images/ProfileImages/1556287445_32333_stitch_pleased_avatar_picture_13166.jpg)
https://www.globenewswire.com/news-release/20...aland.html
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its expansion into the New Zealand market, representing a significant milestone in the Company’s growth strategy for its Intelligent Fingerprinting Drug Screening System.
Drug-related harm in New Zealand equates to a staggering $1.9 billion each year1, with significant societal consequences across communities, workplaces and more. New Zealand employers have a responsibility under the Health and Safety in Employment Act 1992 (HSE Act) to ensure the provision of a safe workplace and take all reasonable measures to safeguard employees while at work2. The HSE Act further requires significant hazards to employees, such as the behaviour of an employee affected by alcohol or drugs, to be eliminated, isolated and minimized3. The Company’s Intelligent Fingerprinting Drug Screening System, which uses fingertip sweat to screen for common drugs of abuse, helps employers to fulfil these legal obligations by offering an efficient, dignified, and non-invasive alternative to traditional and more intrusive point-of-care drug testing methods.
Harry Simeonidis, President and CEO of Intelligent Bio Solutions, said, “We are delighted to announce our expansion into New Zealand and observe another key growth milestone. Our primary focus is to meet the screening needs and support the health and safety initiatives of businesses across New Zealand and around the world. Drawing on our success in Australia over the past six months, we aim to continue this progress in New Zealand and other markets by offering an alternative and innovative solution that places a strong emphasis on operational efficiency, fitness for duty, and employee privacy and dignity.”
The Company’s Intelligent Fingerprinting Drug Screening System is currently available throughout Australia, the United Kingdom, South America, and parts of Europe and Asia, including Spain and Nepal. In addition to these locations, the Company’s growth plan includes further expansion throughout Asia Pacific, the United States and Canada.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)